Replies to post #305147 on Elite Pharmaceuticals Inc (ELTP)

[IB_]

Well now allow me to post a Quote From Nasrat, The CEO of Elite per SA:

"Two months ago, in September, Elite filed a generic APAP with Codeine. The total brand and generic market for APAP with Codeine is about $45 million and our PDUFA date is July of 2019. We filed two other ANDAs earlier this year. One is the ANDA of an immediate release CNS product that we co-developed with our partner SunGen, for which there is a brand and generic sales of approximately $400 million.
Elite is hopeful that this product will be approved in December of this year. That is our PDUFA date. We will wait to hear from FDA. The second ANDA is an extended release CNS product that we co-developed with our partner SunGen. The brand and generic sales of that product, the extended release version is $1.6 billion."

So am I to ascertain that Nasrat The CEO of Elite does not know what he is speaking of in the TWO references to ANDA PDUFA dates above !!!!!!!!!!!!

LoL LoL,

IB_ ;)